Trial intelligence / Profile preview

Esomeprazole pharmacokinetics in hypoalbuminemic critically ill ICU patients

ChiCTR1800018516Phase 4Completed

Sponsor
Lishui City Central Hospital
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of esomeprazole, sponsored by Lishui City Central Hospital. Primary endpoints: Plasma albumin, Blood concentration of esomeprazole and 1 more. Started Jan 2017; status: completed.

02

Drugs

esomeprazole

Beyond the preview

Go deeper on ChiCTR1800018516.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800018516.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call